ISOLOGIC
Live / Applied — Final refusal mailed (as of 25 Sept 2026)
Now
Refused — a final office action was mailed 25 Sept 2026.
A response is due by 25 Dec 2026; with no response the application is abandoned.
What this means for you
Not registered yet, but its 08 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99536121
- Mark type
- Word mark
- Filed
- 08 Dec 2025
- Attorney of record
- Katherine P. Califa
Goods and services
- Class 005 — Pharmaceuticals: Radiopharmaceutical and radioisotope preparations for clinical, medical, medical diagnostic and therapeutic use
- Class 035 — Advertising and business services: Distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations; Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodies
- Class 039 — Transportation and storage services: Supply chain and logistics services, namely, transportation, delivery, distribution in the nature of delivery, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services being the transport and storage of radiopharmaceuticals and radioisotopes
- Class 040 — Treatment of materials: Isotope production being the manufacture of isotopes for products being sold to others for medical, research, and commercial use; contract manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials; Manufacturing services for others in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticals
- Class 042 — Scientific and technological services: Laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services in the field of radiopharmaceutical manufacturing, namely developing and scaling manufacturing processes for radiopharmaceuticals, pharmaceuticals, and nuclear medicine products for others; technological consultancy relating to radiopharmaceutical production and regulatory compliance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others; Scientific and technological services namely, research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine; contract manufacturing services in the field of pharmaceuticals and radiopharmaceuticals
- Class 044 — Medical, beauty and agricultural services: radiopharmacy services, namely, preparation and dispensing of radiopharmaceuticals for diagnostic and therapeutic purposes; consultation and clinical support services related to the preparation and administration of radiopharmaceuticals and radioisotopes
Owner
- Pharmalogic Holdings Corp., Boca Raton, FL, US
Prosecution history
- 25 Sept 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 25 Sept 2026 — FINAL REFUSAL E-MAILED
- 25 Sept 2026 — FINAL REFUSAL WRITTEN
- 24 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Jul 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Jul 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 13 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Apr 2026 — NON-FINAL ACTION E-MAILED
- 13 Apr 2026 — NON-FINAL ACTION WRITTEN
- 13 Apr 2026 — ASSIGNED TO EXAMINER
- 13 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 08 Dec 2025 — NEW APPLICATION ENTERED